michał zarobkiewicz
MEDICAL UNIVERSITY OF LUBLIN, DEPARTMENT OF CLINICAL IMMUNOLOGY
Lublin, Poland
Review Editor
Cancer Immunity and Immunotherapy
Editors
- Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- Editorial board
Type at least 3 characters
Editors
Shape the future of research in your field
Join the board
Review Editors
hassane m zarour
University of Pittsburgh
Pittsburgh, United States
Review Editor
Cancer Immunity and Immunotherapy
ailiang zeng
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Immunity and Immunotherapy
dongqiang zeng
Southern Medical University
Guangzhou, China
Review Editor
Cancer Immunity and Immunotherapy
xian zeng
Fudan University
Shanghai, China
Review Editor
Cancer Immunity and Immunotherapy
zhirui zeng
Guizhou Medical University
Guiyang, China
Review Editor
Cancer Immunity and Immunotherapy
baochun zhang
Dana–Farber Cancer Institute
Boston, United States
Review Editor
Cancer Immunity and Immunotherapy
chuanzhao zhang
Guangdong Provincial People's Hospital
Guangzhou, China
Review Editor
Cancer Immunity and Immunotherapy
chun-dong zhang
The University of Tokyo
Bunkyo, Japan
Review Editor
Cancer Immunity and Immunotherapy
chunyan zhang
City of Hope National Medical Center
Duarte, United States
Review Editor
Cancer Immunity and Immunotherapy
fengyi zhang
Second Xiangya Hospital, Central South University
Changsha, China
Review Editor
Cancer Immunity and Immunotherapy
gang zhang
Zhejiang University
Hangzhou, China
Review Editor
Cancer Immunity and Immunotherapy
guochun zhang
Guangdong Provincial People's Hospital
Guangzhou, China
Review Editor
Cancer Immunity and Immunotherapy
hongru zhang
Nankai University
Tianjin, China
Review Editor
Cancer Immunity and Immunotherapy
huayong zhang
Nanjing University
Nanjing, China
Review Editor
Cancer Immunity and Immunotherapy
jianjun zhang
University of Texas MD Anderson Cancer Center
Houston, United States
Review Editor
Cancer Immunity and Immunotherapy